Aster DM split its Gulf and India hospital businesses in a $1.01bn separation

Aster DM Healthcare, founded by Dr. Azad Moopen in 1987, grew into a network of hospitals, clinics, pharmacies and diagnostics spanning both India and the Gulf, with the combined group listed in Dubai. By late 2023 the structure had become a constraint: the Gulf operations and the Indian operations were pulling the same balance sheet in two directions, and the Dubai-listed shell struggled to reflect the growth of either.

In November 2023 the board approved separating the two businesses. The mechanism put in place that September was a sale: Affinity Holdings, a wholly owned subsidiary of the listed company, would sell its shares in Aster DM Healthcare FZC — the GCC operating business — to Alpha GCC Holdings for $1.01bn. Alpha GCC was itself owned 35:65 by Aster India's promoters and funds managed by Fajr Capital Advisors, an Abu Dhabi-based sovereign-backed private equity firm, and completion was targeted for the fourth quarter of the financial year ending 2024.

Shareholders signed off in January 2024, and on April 3, 2024 the company announced the separation was done. A consortium led by Fajr Capital now owned 65% of Aster GCC, with the Moopen family retaining 35% alongside management and operational rights; Affinity had received $907.6m in cash. In India the family kept a 41.88% stake. Azad Moopen stayed founder chairman of the Indian listco, while his daughter Alisha Moopen took the managing director and group CEO role of the Gulf business.

The decision reads less like an exit than a redrawn map of who owns what. The family swapped concentrated exposure to a dual-market group for parallel stakes in two focused companies — a Gulf healthcare platform backed by sovereign-linked capital, and an India pure-play with its own expansion agenda.

The listed company's subsidiary received $907.6m in cash; the Moopen family kept 35% of the Gulf business plus operational control, and 41.88% of the India business.

One listed company serving two healthcare markets meant the Gulf business's capital needs competed with India's expansion, and neither market's investors could price the whole accurately.

Structuring the buyer as a 35:65 vehicle with the family inside it kept management continuity — patients, doctors and regulators faced the same operators after a change of ownership.

Fajr Capital's sovereign-backed capital gave the Gulf business a growth sponsor aligned with GCC healthcare spending, at a $1.01bn headline value for the stake.

The $907.6m cash settlement went to the listed Indian entity, funding the announced plan to lift India bed capacity toward 6,600 within three years through greenfield and brownfield expansion.

A family group listed in one market but operating in two rarely gets valued for both. Separating geographies lets each business raise capital on its own story, if founders keep skin in both.

Post-separation, the India-listed Aster DM Healthcare set out to become a top-three integrated provider in India, scaling hospitals, labs and pharmacies, while the Gulf business under Alisha Moopen continued operating as Aster across the UAE, Oman and Bahrain. The family's stakes on both sides of the split — 35% in the Gulf, 41.88% in India — bound the two companies together as brand partners despite the separate ownership.